TTNP logo

Titan Pharmaceuticals (TTNP) Shareholders Equity

Annual Shareholders Equity

$6.64 M
+$5.28 M+387.31%

31 December 2023

TTNP Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$3.99 M
-$2.09 M-34.38%

30 June 2024

TTNP Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTNP Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--39.9%
3 y3 years+29.3%-22.3%
5 y5 years+363.5%+178.7%

TTNP Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+387.3%-50.9%+486.3%
5 y5 years-2.8%+387.3%-60.0%+250.2%
alltimeall time-94.2%+128.7%-96.5%+114.7%

Titan Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
June 2024
-
$3.99 M(-34.4%)
Mar 2024
-
$6.09 M(-8.4%)
Dec 2023
$6.64 M(+387.3%)
$6.64 M(-18.3%)
Sept 2023
-
$8.13 M(-886.6%)
June 2023
-
-$1.03 M(+231.4%)
Mar 2023
-
-$312.00 K(-122.9%)
Dec 2022
$1.36 M(-73.5%)
$1.36 M(-61.6%)
Sept 2022
-
$3.55 M(-37.4%)
June 2022
-
$5.67 M(-28.1%)
Mar 2022
-
$7.88 M(+53.4%)
Dec 2021
$5.14 M(+45.5%)
$5.14 M(-31.5%)
Sept 2021
-
$7.50 M(-14.3%)
June 2021
-
$8.75 M(-12.4%)
Mar 2021
-
$9.98 M(+182.6%)
Dec 2020
$3.53 M(+146.5%)
$3.53 M(-493.8%)
Sept 2020
-
-$897.00 K(-157.5%)
June 2020
-
$1.56 M(-70.4%)
Mar 2020
-
$5.28 M(+268.2%)
Dec 2019
$1.43 M(-79.0%)
$1.43 M(-153.9%)
Sept 2019
-
-$2.66 M(+365.8%)
June 2019
-
-$571.00 K(-118.7%)
Mar 2019
-
$3.06 M(-55.3%)
Dec 2018
$6.83 M(+697.1%)
$6.83 M(+24.4%)
Sept 2018
-
$5.49 M(-518.1%)
June 2018
-
-$1.31 M(+55.2%)
Mar 2018
-
-$846.00 K(-198.7%)
Dec 2017
$857.00 K(-93.5%)
$857.00 K(-78.8%)
Sept 2017
-
$4.04 M(-46.4%)
June 2017
-
$7.54 M(-28.9%)
Mar 2017
-
$10.61 M(-19.6%)
Dec 2016
$13.19 M(+88.7%)
$13.19 M(-13.6%)
Sept 2016
-
$15.26 M(-13.7%)
June 2016
-
$17.68 M(+222.9%)
Mar 2016
-
$5.48 M(-21.7%)
Dec 2015
$6.99 M(-18.8%)
$6.99 M(-21.6%)
Sept 2015
-
$8.92 M(+349.0%)
June 2015
-
$1.99 M(-52.6%)
Mar 2015
-
$4.19 M(-51.3%)
Dec 2014
$8.61 M(+49.5%)
$8.61 M(+102.6%)
Sept 2014
-
$4.25 M(+22.8%)
June 2014
-
$3.46 M(-19.1%)
Mar 2014
-
$4.28 M(-25.7%)
Dec 2013
$5.76 M(-124.9%)
$5.76 M(+463.6%)
Sept 2013
-
$1.02 M(-52.4%)
June 2013
-
$2.15 M(-170.4%)
Mar 2013
-
-$3.05 M(-86.8%)
Dec 2012
-$23.13 M(+15.2%)
-$23.13 M(-14.8%)
Sept 2012
-
-$27.13 M(+18.0%)
June 2012
-
-$23.00 M(-2.9%)
Mar 2012
-
-$23.69 M(+18.0%)
Dec 2011
-$20.08 M(+231.7%)
-$20.08 M(+14.4%)
Sept 2011
-
-$17.55 M(+3.3%)
June 2011
-
-$16.98 M(+62.9%)
Mar 2011
-
-$10.43 M(+72.2%)
Dec 2010
-$6.05 M
-$6.05 M(+78.4%)
DateAnnualQuarterly
Sept 2010
-
-$3.39 M(+0.1%)
June 2010
-
-$3.39 M(+109.7%)
Mar 2010
-
-$1.62 M(+11.6%)
Dec 2009
-$1.45 M(-105.7%)
-$1.45 M(-118.8%)
Sept 2008
-
$7.70 M(-41.6%)
June 2008
-
$13.18 M(-34.4%)
Mar 2008
-
$20.10 M(-20.7%)
Dec 2007
$25.35 M(+143.6%)
$25.35 M(+146.9%)
Sept 2007
-
$10.27 M(-27.6%)
June 2007
-
$14.19 M(+95.8%)
Mar 2007
-
$7.25 M(-30.3%)
Dec 2006
$10.40 M(-32.3%)
$10.40 M(-22.2%)
Sept 2006
-
$13.37 M(-23.4%)
June 2006
-
$17.45 M(-15.7%)
Mar 2006
-
$20.70 M(+34.8%)
Dec 2005
$15.36 M(-54.4%)
$15.36 M(-0.7%)
Sept 2005
-
$15.47 M(-29.1%)
June 2005
-
$21.83 M(-20.4%)
Mar 2005
-
$27.43 M(-18.6%)
Dec 2004
$33.71 M(-24.1%)
$33.71 M(-17.8%)
Sept 2004
-
$41.02 M(-12.8%)
June 2004
-
$47.06 M(-10.7%)
Mar 2004
-
$52.72 M(+18.7%)
Dec 2003
$44.43 M(-37.2%)
$44.43 M(-13.4%)
Sept 2003
-
$51.30 M(-10.8%)
June 2003
-
$57.50 M(-10.3%)
Mar 2003
-
$64.12 M(-9.4%)
Dec 2002
$70.74 M(-29.3%)
$70.74 M(-10.9%)
Sept 2002
-
$79.38 M(-8.7%)
June 2002
-
$86.92 M(-7.7%)
Mar 2002
-
$94.17 M(-6.0%)
Dec 2001
$100.13 M(-12.7%)
$100.13 M(-6.2%)
Sept 2001
-
$106.73 M(-3.3%)
June 2001
-
$110.32 M(-1.5%)
Mar 2001
-
$112.00 M(-2.4%)
Dec 2000
$114.74 M(+159.0%)
$114.74 M(+50.2%)
Sept 2000
-
$76.41 M(-5.3%)
June 2000
-
$80.69 M(-2.0%)
Mar 2000
-
$82.36 M(+85.9%)
Dec 1999
$44.30 M(+371.3%)
$44.30 M(+506.8%)
Sept 1999
-
$7.30 M(-23.2%)
June 1999
-
$9.50 M(-24.6%)
Mar 1999
-
$12.60 M(+34.0%)
Dec 1998
$9.40 M(-45.3%)
$9.40 M(-25.4%)
Sept 1998
-
$12.60 M(-17.6%)
June 1998
-
$15.30 M(-12.1%)
Mar 1998
-
$17.40 M(+1.2%)
Dec 1997
$17.20 M(+50.9%)
$17.20 M(-1533.3%)
Sept 1997
-
-$1.20 M(-146.2%)
June 1997
-
$2.60 M(-252.9%)
Mar 1997
-
-$1.70 M(-114.9%)
Dec 1996
$11.40 M(-296.6%)
$11.40 M(-24.5%)
Sept 1996
-
$15.10 M(+277.5%)
June 1996
-
$4.00 M(-37.5%)
Mar 1996
-
$6.40 M(-210.3%)
Dec 1995
-$5.80 M
-$5.80 M

FAQ

  • What is Titan Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Titan Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of TTNP is $6.64 M

What is the all time high annual shareholders equity for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high annual stockholders equity is $114.74 M

What is Titan Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of TTNP is $3.99 M

What is the all time high quarterly shareholders equity for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high quarterly stockholders equity is $114.74 M

What is Titan Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, TTNP quarterly stockholders equity has changed by -$2.65 M (-39.87%)